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Abstract
Introduction. The function and localization of actin in the nucleus have not yet been fully described. However, 
actin seems to be a key protein in nuclear processes interacting with chromatin and matrix proteins. The aim 
of the study was to evaluate the effect of controlled expression of nuclear pool of F-actin and special AT-rich 
sequence-binding protein 1 (SATB1) on the in vitro induction of active cell death by geldanamycin (GA). 
Material and methods. The expression of SATB1 was regulated by the transfection of non-aggressive breast 
cancer MCF-7 cells with siRNA against SATB1 or expression plasmid with cloned cDNA of SATB1. The altered 
expression of cofilin-1 in these cells was used to regulate the nuclear expression and localization of F-actin. The 
effect of GA was analyzed in the context of cell death induction and cell cycle alterations. 
Results. Our studies revealed that the targeted regulation of SATB1 and cofilin-1 expression changed the apo-
ptotic response of the MCF-7 cells to GA. The overexpression of these proteins potentiated GA-induced arrest 
of the cells in the G1 phase of cell cycle and increased the population of the hypodiploid cells.
Conclusion. The alterations in the nuclear expression of SATB1 and F-actin in MCF-7 cells may affect their 
active cell death in response to GA. (Folia Histochemica et Cytobiologica 2015, Vol. 53, No. 1, 79–87)
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Introduction
It has been suggested for decades that nuclear actin 
exists only in a globular form (G-actin). The early 
studies that reported the presence of polymerized 
form of nuclear actin were treated with skepticism 
and this issue has been questioned [1]. However, in-
creasing body of evidence showing the nucleoplasmic 
localization of F-actin suggested that it may interact 
with other nuclear matrix proteins [1–6]. Moreover, 
there are a number of reports linking nuclear actin 
with chromatin remodeling during several nuclear 
processes [5, 7–13]. For instance, the association 
of nuclear actin, chromatin remodeling and RNA 
polymerase II transcription has been demonstrated 
[9]. It has also been speculated that under stress 
conditions, cytoplasmic actin may translocate into 
the cell nucleus to function as a modulator of gene 
transcription [14–16]. Furthermore, numerous pro-
teins which interact with G- and F-actin have been 
detected in the nucleus [17, 18]. Nevertheless, the 
direct involvement of actin filaments in transcription 
and chromatin remodeling has been questioned [19]. 
Some authors have shown that nuclear actin filaments 
are too short to serve as tracks for chromatin dynamics 
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in the nucleus [6, 20]. They have also referred to the 
lack of directed movement of nuclear actin filaments 
and the lack of colocalization between nuclear actin 
filaments and nuclear myosin [6]. Results of other 
studies suggested that the conformational alterations 
and some post-translational changes of nuclear actin 
may be responsible for differences in its polymeriza-
tion propensities [21–23]. 
SATB1 (Special AT-rich Sequence-Binding Prote-
in 1) is a nuclear matrix protein that binds specifically 
to the AT-rich sequences of DNA by recognizing the 
base unpairing regions (BURs) [24]. This protein 
coordinates the control of the expression of various 
genes even in distant parts of the genome through 
the regulation of chromatin-loop architecture and 
transcription. SATB1 forms three-dimensional func-
tional cage-like structures inside the cell nucleus 
which anchor chromosomes by tethering the BUR 
regions of the selected genes [25]. Some authors 
implicated SATB1 also in the regulation of apoptotic 
cell death [26–29], since degradation of SATB1 was 
found in cells undergoing apoptosis [27, 28, 30]. We 
have previously shown that SATB1/nuclear F-actin 
complex is localized at the border of condensed and 
decondensed chromatin, which suggests its involve-
ment in the process of transcription [31]. We have 
also demonstrated F-actin presence in the cell nucleus 
of different cell lines treated with anti-cancer drugs 
and speculated that nuclear F-actin may be involved 
in chromatin remodeling processes during apoptosis 
and mitotic catastrophe [32–36]. To date, no studies 
have described the possible association between 
the apoptotic process and the alterations in SATB1 
expression. Moreover, effects of the altered SATB1 
expression on the cell cycle have not yet been studied. 
Therefore, the aim of this study was to evaluate the 
effect of controlled expression of the nuclear pool of 
F-actin and SATB1 protein on the in vitro induction 
of active cell death by geldanamycin (GA), a HSP90 
blocker.
Material and methods
Cell culture and treatment. Human breast adenocarcinoma 
MCF-7 cell line was purchased from American Type Culture 
Collection (ATCC; HTB-22). The cells were grown in cell 
culture flasks or 6- and 12-well plates (BD Biosciences, Fran-
klin Lakes, NJ, USA) in a monolayer culture in Minimum 
Essential Medium Eagle (MEM; Sigma-Aldrich, St. Louis, 
MO, USA) with 10% fetal bovine serum (FBS; Gibco/Life 
Technologies, Carlsbad, CA, USA) and 50 µg/ml gentamycin 
(Sigma-Aldrich) at 37°C in a humidified CO2 incubator (5% 
CO2). 72 hours after transfection with siRNA or expression 
plasmid, the cells were incubated with 2 µM GA (Sigma-Al-
drich) for another 24 hours. Stock solutions of GA were pre-
pared in 100% dimethyl sulfoxide (Sigma-Aldrich), stored 
at –25°C and serially diluted in complete growth medium 
immediately before use. The control cells were grown under 
the same conditions without addition of GA.
Transfection by nucleofection. For the nucleofection of 
MCF-7 cells, the cells were grown in cell culture flasks (BD 
Biosciences) up to 80–90% confluence in MEM with the 
addition of FBS (Gibco/Life Technologies) and 50 µg/ml 
gentamycin (Sigma-Aldrich). After trypsinization, a to-
tal of 2 × 106 cells were transfected using SE Cell Line 
4D-Nucleofector X Kit according to the manufacturer’s 
instructions. Briefly, the cells were suspended in 100 µl of 
the mixture containing SE Nucleofector Solution, together 
with 3 pmol siRNA against human SATB1 (Hs_SATB1_3; 
Qiagen, Hilden, Germany), 3 pmol siRNA against human 
cofilin-1 (Hs_CFL1_3), 2 µg human cDNA of SATB1 cloned 
into pCMV6-XL5 expression plasmid vector (NM_002971; 
OriGene, Rockville, MD, USA) or 2 µg human cDNA of 
cofilin-1 cloned into pCMV6-XL5 expression plasmid vec-
tor (NM_005507; OriGene, Maryland, USA), respectively. 
Then, the mixture was transferred into transfection cuvettes. 
The electroporation was done using 4D-Nucleofector device 
(Lonza, Verviers, Belgium) under the program EN-130. 
As a negative control, the commercially designed AllStars 
negative control siRNA (Qiagen) or pCMV6-XL5 control 
plasmid vector (OriGene) were used. After transfection, 
the cells were grown in medium without antibiotics for 
72 h and then they were used for further experiments. The 
downregulation or overexpression of SATB1 and cofilin-1 
by siRNASATB1, siRNACFL1, pCMV6-XL5SATB1 expression 
plasmid or pCMV6-XL5CFL1 expression plasmid were con-
firmed by Western blot method.
Western blotting. The semi-quantitative analysis of the 
post-translational expression of SATB1 and cofilin-1 was 
performed by Western blot analysis. After transfection 
and treatment of MCF-7 cells, they were lysed with RIPA 
buffer (Sigma-Aldrich). After normalization of protein 
concentration by BCA Protein Assay Kit (Thermo Scientific 
Pierce, Rockford, IL, USA), the 15 µg of total protein per 
lane was separated by 4–12% NuPage Bis-Tris gel (Novex/ 
/Life Technologies, Carlsbad, CA, USA) and transferred 
to the nitrocellulose membrane using iBlot dry Western 
blotting system (Invitrogen/Life Technologies). Pre-stained 
molecular weight markers (Novex/Life Technologies) were 
used to estimate the position of protein bands. After that, 
the membrane was processed using WesternBreeze Chromo-
genic Western Blot Immunodetection Kit (Invitrogen/Life 
Technologies, Carlsbad, CA, USA) by BenchPro 4100 card 
processing station (Invitrogen/Life Technologies) according 
to manufacturer’s instructions. Briefly, the membranes were 
blocked with WesternBreeze Blocking Solution for 30 min 
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and incubated with primary rabbit monoclonal anti-SATB1 
(1:1,000; Abcam, Cambridge, MA, USA), rabbit anti-cofilin 1 
(1:1,000; Sigma-Aldrich) or rabbit polyclonal anti-GADPH 
(1:2,000; Sigma-Aldrich) antibodies diluted in blocking so-
lution for 2 h in room temperature (RT). After washing, the 
membranes were incubated for 1 h in RT with ready-to-use 
solution of alkaline phosphatase-conjugated anti-species 
IgG (Invitrogen/Life Technologies). The immunoreactive 
bands were then visualized using ready-to-use solution of 
BCIP/NBT substrate for alkaline phosphatase (Invitrogen/ 
/Life Technologies). After scanning, the densitometry of the 
bands was quantified using the Quantity One Basic software 
(Ver. 3.6.5; Bio-Rad, Hercules, CA, USA).
Cell death analysis. The analysis of cell death was performed 
using Tali Image-based cytometer (Invitrogen/Life Techno-
logies) and Tali Apoptosis Kit (Invitrogen/Life Technolo-
gies) according to manufacturer’s instructions. Briefly, after 
transfection and treatment, the cells were harvested and 
resuspended in Annexin Binding Buffer (ABB) at a concen-
tration of ~5 × 105 to 5 × 106. After that, to each of 100 µL 
sample, 5 µL of Annexin V Alexa Fluor 488 were added and 
incubated at RT in the dark for 20 min. Then, the cells were 
centrifuged at 300 g for 5 min and resuspended in 100 µL of 
ABB. After the addition of 1 µL of propidium iodine (PI) 
to each sample, the cells were incubated at RT in the dark 
for 3 min. 25 µL of stained cells were then loaded into a Tali 
Cellular Analysis Slide (Invitrogen/Life Technologies). The 
data were analyzed using FlowJo software (Ver. 10; Tree 
Star, Ashland, OR, USA) on assumption that viable cells 
are both Annexin V Alexa Fluor 488- and PI-negative cells. 
Cells in various stages of apoptosis were Annexin V Alexa 
Fluor 488-positive and PI-negative or PI-positive, whereas 
necrotic cells were Annexin V Alexa Fluor 488-negative 
and PI-positive.
Cell cycle analysis. The analysis of cell cycle was performed 
using Tali Image-based cytometer (Invitrogen/Life Techno-
logies) and Tali Cell Cycle Kit (Invitrogen/Life Technolo-
gies) according to manufacturer’s instructions with some 
modifications. Briefly, after transfection and treatment, 
the cells were harvested and resuspended in PBS. After 
centrifugation (300 g, 5 min), the cells were fixed in 70% 
ice-cold ethanol and incubated overnight. The next day, 
the cells were washed in cold PBS, resuspended in 200 µL 
of Tali Cell Cycle Solution and incubated for 30 min at RT 
in the dark. 25 µL of stained cells were then loaded into 
a Tali Cellular Analysis Slide (Invitrogen/Life Technologies). 
The data were analyzed using FlowJo software (Ver. 10; 
Tree Star).
Statistical analysis. The data were shown as mean ± SEM. 
Statistical comparisons between two groups of cell death or 
cell cycle data were performed with Mann-Whitney U test. 
The differences between the groups were considered signi-
ficant at p ≤ 0.05. The GraphPad Prism 5.0 (GraphPad Soft-
ware, La Jolla, CA, USA) was used for statistical analyses.
Results
Analysis of post-translational down-regulation  
and overexpression of SATB1 and cofilin-1  
in the MCF-7 cells
Western blot analysis (Figure 1A, B) confirmed 
altered expression of both SATB1 and cofilin-1 in 
comparison with appropriate control after the trans-
fection of MCF-7 cells with siRNASATB1, siRNACFL1, 
pCMV6-XL5SATB1 expression plasmid or pCMV6-XL-
5CFL1 expression plasmid. 
Densitometric analysis showed a decrease in 
SATB1 (34.51% of initial expression) and cofilin-1 
(26.75% of initial expression) post-translational 
expression in the cells transfected with siRNASATB1 and 
siRNACFL1, as compared with the cells transfected with 
non-targeting siRNA, respectively (Figure 1A, B). 
A B
Figure 1. Post-transcriptional expression of SATB1 and cofilin-1 in the MCF-7 cells. A. Post-transcriptional expression  
of SATB1 in the cells transfected with siRNA against SATB1 or pCMV6-XL5 expression plasmid with cloned cDNA  
of SATB1; B. Post-transcriptional expression of cofilin-1 in the cells transfected with siRNA against cofilin-1  
or pCMV6-XL5 expression plasmid with cloned cDNA of cofilin-1
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Figure 2. Relative number of the Annexin V-positive MCF-7 cells after the 24 h treatment with 2 µM geldanamycin.  
A. Cells transfected with non-targeting siRNA; B. Cells transfected with pCMV6-XL5 empty plasmid; C. Cells transfected 
with siRNA against SATB1; D. Cells transfected with pCMV6-XL5 expression plasmid with cloned cDNA of SATB1; 
E. Cells transfected with siRNA against cofilin-1; F. Cells transfected with pCMV6-XL5 expression plasmid with cloned 
cDNA of cofilin-1. Data are expressed as the ratio of the percentage of Annexin V-positive cells after exposition to 2 µM 




Transfection of the cells with pCMV6-XL5SATB1 
and pCMV6-XL5CFL1 increased post-translational 
expression of SATB1 (134.3% of initial expression) 
and cofilin-1 (127.8% of initial expression) in com-
parison with the cells transfected with pCMV6-XL5 
plasmids without cloned cDNA of SATB1 and CFL1 
(Figure 1A, B).
Alterations in SATB1 and cofilin-1 expression 
change apoptotic response of MCF-7 cells  
to geldanamycin
The quantitative analysis of cell death was performed 
using Tali Image-based cytometer after Annexin V 
Alexa Fluor 488 and propidium iodide double sta-
ining. To avoid the miscount of spontaneous apoptosis 
induced by the regulation of SATB1 and cofilin-1 
expression, the data were presented as relative An-
nexin V-positive cell counts (ratio of the percentage of 
Annexin V-positive cells after exposition to 2 µM GA 
to the percentage of Annexin V-positive control cells). 
As shown in Figure 2, treatment of the MCF-7 cells 
transfected with non-targeting siRNA (Figure 2A) or 
empty plasmid (Figure 2B) with 2 µM GA increased 
the relative number of Annexin V-positive cells.
After down-regulation of SATB1 expression by 
siRNASATB1, the relative population of apoptotic cells 
following exposition to 2 µM GA significantly decre-
ased (Figure 2C). In turn, overexpression of SATB1 
by pCMV6-XL5SATB1 in MCF-7 cells treated with 
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GA almost doubled the relative number of Annexin 
V-positive cells (Figure 2D). 
The down-regulation of cofilin-1 expression by 
siRNACFL1 in the cells incubated with GA, did not 
change the relative number of apoptotic cells (Figu-
re 2E). However, the overexpression of cofilin-1 by 
expression plasmid pCMV6-XL5CFL1 increased by 
a factor of 2.5 the relative number of apoptotic cells 
after their treatment with 2 µM GA (Figure 2F).
Overexpression of SATB1 and cofilin-1 in MCF-7 
cells augments geldanamycin-induced arrest  
in the G1 phase of the cell cycle and increases  
population of hypodiploid cells
The image-based cytometry analysis using the DNA 
intercalator dye, propidium iodide, was applied to 
determine the percentage of cells in each phase of 
the cell cycle. To avoid the miscount of spontaneous 
changes in the cell cycle distribution induced by the 
alterations in SATB1 and cofilin-1 expression, the 
data were presented as relative numbers (ratio of the 
percentage of cells in appropriate phase of the cell 
cycle after exposition to 2 µM GA to the percentage 
of control cells in the same phase of the cell cycle). 
Treatment of the MCF-7 cells with 2 µM GA in-
creased the relative number of cells with hypodiploid 
DNA content (subG1 phase) in the cells transfec-
ted with either non-targeting siRNA (Figure 3A) 
or empty plasmid (Figure 3B). Concomitantly, the 
population of cells in the G1 phase significantly 
increased, whereas the proportion of cells in the 
S phase significantly decreased (Figures 3A and 3B, 
respectively). Moreover, the exposure of the MCF-7 
Figure 3. Relative number of the MCF-7 cells in particular phases of cell cycle after the 24 h treatment with 2 µM geldana- 
mycin. A. Cells transfected with non-targeting siRNA; B. Cells transfected with pCMV6-XL5 empty plasmid; C. Cells 
transfected with siRNA against SATB1; D. Cells transfected with pCMV6-XL5 expression plasmid with cloned cDNA 
of SATB1; E. Cells transfected with siRNA against cofilin-1; F. Cells transfected with pCMV6-XL5 expression plasmid  
with cloned cDNA of cofilin-1. Data are expressed as the ratio of the percentage of cells in appropriate phase of the 
cell cycle after exposition to 2 µM GA to the percentage of control cells in the same phase of the cell cycle
A C E
B D F
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cells transfected with non-targeting siRNA to 2 µM 
GA resulted in the reduction of the number of poly-
ploid cells (Figure 3A). 
Interestingly, similar results were observed in the 
cells with down-regulated SATB1 expression which 
were transfected with siRNASATB1. In these cells, after 
exposure to 2 µM GA, increases in subG1 and G1 
population, and decreases in S phase and polyploid 
populations were observed (Figure 3C). The down
-regulation of cofilin-1 did not change the number 
of cells in G2 phase after GA treatment (Figure 3C).
GA treatment of MCF-7 cells with SATB1 over-
expression increased the number of hypodiploid 
cells that was accompanied by the decreases in the 
population of polyploid cells and cells in S and G2 
phases (Figure 3D). 
The down-regulation of cofilin-1 expression in 
the MCF-7 cells exposed to 2 µM GA increased the 
proportion of subG1 and polyploid cells, decreased 
number of cells in the S phase, and did not change 
the proportion of cells in the G2 phase of the cell 
cycle (Figure 3E). 
Cofilin-1 overexpression in the MCF-7 cells tre-
ated with 2 µM GA resulted in the increased popula-
tion of cells in subG1 and G1 phases, and decreased 
population of the S phase cells and polyploid cells 
(Figure 3F).
Discussion
The aim of the study was to evaluate the effect of 
controlled expression of SATB1 and F-actin in the 
nucleus of MCF-7 cells on GA-induced cell death and 
changes in cell cycle. Human breast cancer line used, 
regarded as a non-aggressive one, has been widely 
used as a model in the studies of the SATB1 protein 
due to its easy-to-control expression level [37–40]. 
There are studies showing that SATB1 reprograms 
chromatin organization and transcription profiles 
of breast tumors to promote growth and metasta- 
sis [39]. Cancer growth represents an imbalance between 
cell proliferation and cell death and there is a great 
need for improving the systemic therapy for breast 
cancer which is still most frequently diagnosed type 
of cancer and a leading cause of cancer death among 
women [41]. 
Geldanamycin has been often used as a model 
agent which inhibits Hsp 90 activity. However, the 
effects of the Hsp90 inhibition are very complex and 
depend on the biochemical features and molecular 
background of treated cells [42]. The reported cell 
cycle effects are mostly G1 and G2/M arrest [43–46]. 
Here, after GA treatment of MCF-7 cells, we ob-
served the increased incidence of apoptosis and the 
decreased frequency of polyploid cells with the featu-
res of mitotic catastrophe. Moreover, we found that 
overexpression of SATB1 in these cells promoted the 
increase in the percentage of subG1 cells and Annexin 
V-positive cells. A similar effect was observed here 
after increasing the nuclear transport of actin by co-
filin-1 overexpression. These results suggest that in 
the MCF-7 cells, the SATB1 protein may be directly 
involved in the apoptotic process through its possible 
cooperation with nuclear F-actin.
It can be also expected that SATB1 and nuclear 
F-actin may jointly act to support alterations in chroma-
tin architecture during an active process of cell death. 
Sun et al. showed that three-dimensional network of 
SATB1 during early apoptosis was associated with the 
cleavage of this protein and was accompanied by the 
nuclear architecture collapse which was mediated by 
caspase-3 [47]. They also suggested that the architectural 
changes of chromatin during early apoptosis supported 
by SATB1 network reorganization could be a mecha-
nism that renders matrix-associated regions of DNA 
exposed to endonucleolysis [47]. Galande et al., using 
Jurkat cells as an experimental model, demonstrated 
that during apoptosis SATB1 is also cleaved by a caspase 
6-like protease resulting in the loss of its BUR-binding 
activity and dissociation from chromatin [27].
It has been shown that actin may translocate 
into the cell nucleus to function as a transcriptional 
modulator of gene expression [5, 7–16]. Our earlier 
studies have demonstrated not only the translocation 
of actin into the nucleus but also the involvement 
of nuclear F-actin in chromatin remodeling during 
cell death processes [32–36]. The results presented 
in this paper suggest that SATB1 may be involved 
together with F-actin in chromatin reorganization 
during cell death. Indeed, the association between 
nuclear F-actin and SATB1 and their involvement in 
chromatin remodeling during cell death was observed 
by us in CHO AA8 cell line [31] and in Jurkat cells [48]. 
Our previous observations suggest also that the 
expression of cofilin-1 is essential for the activation 
of cell death [35]. Here, after exposure of MCF-7 
cell with overexpression of cofilin-1 to 2 µM GA, 
we observed a significant increase of apoptotic cell 
population and decrease in the number of polyploid 
cells. Furthermore, Chua et al. have revealed that 
cofilin-1 plays a key role during the initiation phase 
of apoptosis. This type of cell death is mediated by 
the translocation of cofilin-1 to mitochondria, causing 
the release of cytochrome c, the activation of caspa-
se-3 and caspase-9 as well as the condensation and 
fragmentation of chromatin [49, 50]. It has also been 
suggested that oxidant-induced apoptosis and mito-
chondrial integrity could be regulated through the 
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oxidation of cofilin-1 [51]. Other studies have shown 
the reduced release of cytochrome c and the block of 
apoptosis upon siRNA-induced cofilin-1 knockdown. 
Rehklau et al., studying embryonic fibroblasts 
deficient for cofilin-1 and actin depolymerizing fac-
tor (ADF), showed that ADF/cofilin activity is not 
essential for the initiation or progress of apoptosis 
in mammalian cells [52]. In the MCF-7 cells with the 
decreased expression of cofilin-1, no statistically si-
gnificant differences were found in the relative value 
of Annexin-positive cells. The data of this report are 
also in agreement with our earlier results and indicate 
that the presence of F-actin in the nucleus is a key 
event during GA-induced apoptosis in the MCF-7 
cells [31]. The direct role of SATB1 in the induction 
of this process was also confirmed. In the present 
study, we observed the decrease in Annexin V-positive 
cells in the response to siRNASATB1 treatment. These 
observations have also been confirmed by our studies 
on the model of Jurkat cells [48]. 
Other reports also link SATB1 protein with early 
events in apoptosis. Gong et al. suggested that SATB1 
cleavage at a very early stage of apoptosis results in 
down-regulation of Bcl-2 expression and modulates 
the association of SATB1 with the mbr and the pro-
moter. They also showed that the inhibition of SATB1 
cleavage by the treatment of cells with caspase-6 
inhibitor repressed the disassembly of the SATB1-me-
diated chromatin loops and restored Bcl-2 expression 
level [53]. The correlation between SATB1 and Bcl-2 
expression was found in glioblastoma and embryonal 
carcinoma [54, 55]. Some other reports have presen-
ted additional data showing the association between 
SATB1 and HIF-1a expression together with the co
-expression of androgen receptor (AR), estrogen re-
ceptor (ER), and Bcl-2 in breast cancer [56]. How ever, 
any direct relationship between SATB1 and Bcl-2 
immunohistochemical expression was found in a tissue 
microarray study of a breast ductal carcinoma [56]. Of 
note, in one study a moderate correlation between the 
expression of SATB1 and proliferation marker Ki-67 
in ER-negative breast tumors was found [57]. More-
over, Kowalczyk et al. demonstrated the lower SATB1 
mRNA content in both tumor tissue and unchanged 
mucosa of colorectal carcinoma (CRC) patients than 
in the normal colon mucosa, while SATB1 protein 
levels in colorectal tissues of CRC patients were si-
gnificantly higher than those in the colon mucosa of 
healthy controls. It suggest that post-transcriptional 
events limit the SATB1 expression in CRC [58].
In summary, we showed here that the alterations 
in SATB1 and cofilin-1 expression affected apoptotic 
response of the MCF-7 cells to GA. Moreover, cell 
cycle studies confirmed that the overexpression of 
these proteins amplify the response of geldanamycin
-induced arrest of cells in G1 phase of cell cycle and 
increased population of hypodiploid cells. Together 
with our previous results, we conclude here that the 
nuclear expression and localization of both SATB1 
and F-actin is required for the induction of active 
cell death.
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